ipsas 29—financial instruments: recognition and measurement - IFAC
ipsas 29—financial instruments: recognition and measurement - IFAC
ipsas 29—financial instruments: recognition and measurement - IFAC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
FINANCIAL INSTRUMENTS: RECOGNITION AND MEASUREMENT<br />
dividends or similar distributions <strong>and</strong> changes in fair value), <strong>and</strong><br />
evaluates its performance on that basis. The portfolio may be held to<br />
back specific liabilities, net assets/equity or both. If the portfolio is held<br />
to back specific liabilities, the condition in paragraph 10(b)(ii) may be<br />
met for the assets regardless of whether the insurer also manages <strong>and</strong><br />
evaluates the liabilities on a fair value basis. The condition in<br />
paragraph 10(b)(ii) may be met when the insurer’s objective is to<br />
maximize total return on the assets over the longer term even if<br />
amounts paid to holders of participating contracts depend on other<br />
factors such as the amount of gains realized in a shorter period (e.g., a<br />
year) or are subject to the insurer’s discretion.<br />
AG15. As noted above, this condition relies on the way the entity manages <strong>and</strong><br />
evaluates performance of the group of financial <strong>instruments</strong> under<br />
consideration. Accordingly, (subject to the requirement of designation at<br />
initial <strong>recognition</strong>) an entity that designates financial <strong>instruments</strong> as at fair<br />
value through surplus or deficit on the basis of this condition shall so<br />
designate all eligible financial <strong>instruments</strong> that are managed <strong>and</strong> evaluated<br />
together.<br />
AG16. Documentation of the entity’s strategy need not be extensive but should<br />
be sufficient to demonstrate compliance with paragraph 10(b)(ii). Such<br />
documentation is not required for each individual item, but may be on a<br />
portfolio basis. For example, if the performance management system<br />
within an entity as approved by the entity’s key management personnel –<br />
clearly demonstrates that its performance is evaluated on a total return<br />
basis, no further documentation is required to demonstrate compliance<br />
with paragraph 10(b)(ii).<br />
Effective Interest Rate<br />
AG17. In some cases, financial assets are acquired at a deep discount that reflects<br />
incurred credit losses. Entities include such incurred credit losses in the<br />
estimated cash flows when computing the effective interest rate.<br />
AG18. When applying the effective interest method, an entity generally amortizes<br />
any fees, points paid or received, transaction costs <strong>and</strong> other premiums or<br />
discounts included in the calculation of the effective interest rate over the<br />
expected life of the instrument. However, a shorter period is used if this is<br />
the period to which the fees, points paid or received, transaction costs,<br />
premiums or discounts relate. This will be the case when the variable to<br />
which the fees, points paid or received, transaction costs, premiums or<br />
discounts relate is repriced to market rates before the expected maturity of<br />
the instrument. In such a case, the appropriate amortization period is the<br />
period to the next such repricing date. For example, if a premium or<br />
discount on a floating rate instrument reflects interest that has accrued on<br />
the instrument since interest was last paid, or changes in market rates since<br />
IPSAS 29 APPLICATION GUIDANCE 1074